In 1991 Dr Fearnhead completed a BSc. in Pharmacology and Toxicology at the London School of Pharmacy, before beginning a PhD. in apoptosis at the MRC-Toxicology Centre, Leicester, UK.  In 1995 Dr Fearnhead began a post-doctoral fellowship at Cold Spring Harbor Laboratory, NY before becoming a principal investigator at the National Cancer Institute in Frederick, Maryland.  In 2004 Dr Fearnhead moved to the National Centre of Biomedical Engineering Science (NCBES), National University of Ireland, Galway and in 2006 was appointed a lecturer in the discipline of Pharmacology and Therapeutics.

Research interests 
My research focus is entirely cell death and cell death mechanisms with two main ideas being the focus of investigation:  the roles of the apoptotic death machinery in inducing cell differentiation, tissue repair and tumourigenesis; and (2) exploiting synthetic lethality and collateral sensitivity to treat cancers that are resistant to current chemotherapy. The goal of both projects is a better understanding how cells, and particularly cancer cells make life-and-death decisions.

Link to Recent Publications

Contact details 
Tel: 00 353 91 495240, Ext. 5240